Pfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer Pfizer Inc. (NYSE: PFE) has announced promising results from the Phase 3 TALAPRO-2 study, which tested TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with…
GeneDx Launches 48-Hour Whole Genome Sequencing for Critical NICU and PICU Patients GeneDx (Nasdaq: WGS), a leader in genomic health insights, has unveiled ultraRapid Whole Genome Sequencing, providing quick, comprehensive genomic results for neonatal and pediatric patients in the NICU…
HealthStream’s CredentialStream® Achieves HITRUST r2 Certification for Top Healthcare Data Security HealthStream (Nasdaq: HSTM), a leading healthcare technology provider for workforce solutions, announced today that its SaaS-based CredentialStream application, along with CredentialStream Hub and Network by HealthStream, has received HITRUST…
Newleos Therapeutics Raises $93.5 Million in Oversubscribed Series A to Transform Neuropsychiatric Disorder Treatments Newleos Therapeutics, Inc., a clinical-stage neuroscience company co-founded by Longwood Fund and experienced leaders in CNS drug development, has successfully closed an oversubscribed $93.5 million Series…
CareDx to Present AlloHeme Data at 2025 Tandem Meetings on Early Relapse Detection CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine focused on transplant patients and caregivers, today announced the presentation of new AlloHeme data at the 2025 Tandem…
CharmHealth Launches Marketplace and Innovation Hub for Healthcare Ecosystem CharmHealth, a leader in healthcare technology solutions for providers, today introduced the CharmHealthHub, a premium marketplace designed to connect a wide range of healthcare stakeholders, including providers, practice groups, patients, entrepreneurs,…
Ensoma Gets Pediatric Disease and Orphan Drug Designations for EN-374 in Chronic Granulomatous Disease Ensoma, a genomic medicines company focused on developing one-time, in vivo treatments to precisely and durably engineer the hematopoietic system, announced that the U.S. Food and…
GE HealthCare Announces Q4 and Full Year 2024 Financial Results GE HealthCare (Nasdaq: GEHC) reported its financial results for the fourth quarter and full year ended December 31, 2024, showing solid growth and progress across various sectors. Peter Arduini, President…
Latent Labs Raises $50M to Advance AI-Powered Programmable Biology Latent Labs, an AI-driven biotechnology company, has emerged from stealth mode with $50 million in total funding to accelerate its development and foster strategic partnerships. The company, founded by Dr. Simon…
Clinical Study Confirms Lubrizol MAGSHAPE™ Enhances Magnesium Absorption Lubrizol’s MAGSHAPE™ microcapsules, a micronized and microencapsulated form of magnesium, have been found to significantly improve magnesium absorption compared to other commonly used magnesium sources, according to a recent study published in…
Four CHLA Units Win Beacon Healthcare Awards from AACN Children’s Hospital Los Angeles (CHLA) has proudly announced that four of its inpatient care units have been honored with the prestigious 2024 Beacon Awards for Excellence by the American Association of…
Dignity Health Enhances Community Ties with Bakersfield Arena and Venue Partnership The City of Bakersfield, California, has partnered with Dignity Health to expand their naming-rights agreement for one of the region’s key venues. The downtown complex, formerly known as Centennial…